![A technician wearing gloves holds a colonoscopy scope](https://www.uc.edu/news/articles/2023/03/n21156134/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1678909231567.jpg)
WLWT: UC expert discusses colorectal cancer screening recommendations
March is Colon Cancer Awareness Month, and the University of Cincinnati Cancer Center's Carla F. Justiniano, MD, discussed the importance of screening with WLWT's Meredith Stutz.
In 2021, the recommended screening age for colorectal cancer was decreased from 50 to 45. But Justiniano noted people with a family history of colorectal cancer may need to be screened even earlier, 10 years before the family member was diagnosed. So if a parent was diagnosed at age 49, their child may want to start screening at age 39.
"I think, you know, that the repercussions of having an early cancer that gets cut, that is caught during a screening colonoscopy versus having something very advanced, is so different," said Justiniano, a Cancer Center colorectal surgeon and assistant professor in UC's College of Medicine. "You know, if you have an early rectal cancer caught in a colonoscopy, you can have minimally invasive surgery or approaches. Maybe you don't even need your rectum removed, things like that. And your life could very much go on without too much change."
Featured photo at top courtesy of iStock Photo.
Related Stories
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
Physics World names UC, Cincinnati Children's study among top 10 Breakthroughs of 2022
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
Dermatology Times features UC research of nail squamous cell carcinoma treatment
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
GEN News: Biomarker discovery to help predict breast cancer outcomes
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
Healio: Sleep, diet among keys to preserving cognitive function during cancer survivorship
September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
OncLive and Targeted Oncology: Drug yields long-lasting benefits to treat PEComa tumors
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.
MedPage Today: Promising results for living donor transplants
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.